DRI Healthcare delays London flotation, blaming Covid-19 meltdown
DRI Healthcare, the Canadian investment fund focused on pharmaceutical royalties, has postponed its $350m IPO on the London Stock Exchange, blaming the global equity market selloff caused by the spread of the Covid-19 virus.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: